Roundtable Discussion: Utilizing the Most Optimal Analytical Assays to Support Your Exosome Drug Product Release Strategies
- Evaluating conventional and novel instruments to analyze exosomes across ELISA, acoustic Imaging, flow cytometry, and more to confidently select your technology
- Ensuring analytical methods are validating, qualifying, and reproducible to ensure safety and sterility of the exosome product
- One vs multiple potency assays – How to address complex mechanisms of action within the production phase